Your browser doesn't support javascript.
loading
Surveillance for azoles resistance in Aspergillus spp. highlights a high number of amphotericin B-resistant isolates.
Reichert-Lima, Franqueline; Lyra, Luzia; Pontes, Lais; Moretti, Maria Luiza; Pham, Cau D; Lockhart, Shawn R; Schreiber, Angélica Zaninelli.
Afiliação
  • Reichert-Lima F; Clinical Pathology Department, School of Medical Sciences, State University of Campinas, Sao Paulo, Brazil.
  • Lyra L; Clinical Pathology Department, School of Medical Sciences, State University of Campinas, Sao Paulo, Brazil.
  • Pontes L; Clinical Pathology Department, School of Medical Sciences, State University of Campinas, Sao Paulo, Brazil.
  • Moretti ML; Internal Medicine Department, School of Medical Sciences, State University of Campinas, Sao Paulo, Brazil.
  • Pham CD; Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Lockhart SR; Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Schreiber AZ; Clinical Pathology Department, School of Medical Sciences, State University of Campinas, Sao Paulo, Brazil.
Mycoses ; 61(6): 360-365, 2018 Jun.
Article em En | MEDLINE | ID: mdl-29468746
Aspergillus spp. are the most common invasive mould infection and are responsible for high mortality. Aspergillus fumigatus is currently of interest because resistance to azole antifungals has emerged. The Campinas University Hospital (HC-UNICAMP) receives high-risk patients susceptible to opportunistic infections but there have been no reports of resistant A. fumigatus. This study aimed to assess the susceptibility profile of Aspergillus isolates, specifically looking for azole resistance. ITS and ß-tubulin DNA sequencing was performed on 228 sequential clinical isolates. Broth microdilution susceptibility testing was performed for all isolates. A. fumigatus represented 74% of the isolates followed by Aspergillus flavus (12%). Nine A. fumigatus isolates from 9 different patients showed high MIC values to at least 1 azole, but cyp51A polymorphisms were detected in only 6 isolates and none correlated with known resistance mutations. The most troubling observation was that the minimum inhibitory concentration for amphotericin B was elevated (≥2 mg L-1 ) in 87% of patients with A. flavus isolates and 43% with Aspergillus fumigatus isolates. Given that amphotericin B is used to treat azole-resistant infections, these data highlight the need for continuous surveillance in Aspergillus for all antifungal resistance to implement correct treatment strategies for the management of these pathogens.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aspergillus / Azóis / Anfotericina B / Farmacorresistência Fúngica / Antifúngicos Tipo de estudo: Screening_studies Limite: Humans Idioma: En Revista: Mycoses Assunto da revista: MICROBIOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Brasil País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aspergillus / Azóis / Anfotericina B / Farmacorresistência Fúngica / Antifúngicos Tipo de estudo: Screening_studies Limite: Humans Idioma: En Revista: Mycoses Assunto da revista: MICROBIOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Brasil País de publicação: Alemanha